<DOC>
	<DOCNO>NCT01217190</DOCNO>
	<brief_summary>The purpose study assess single dose bioequivalence Ondansetron OSF 8mg ( Manufactured MonoSol Rx , USA ) Zofran ODT® ( Containing Ondansetron 8 mg ) ( Manufactured Cardinal Heasth Blagrove , Swindon , Wiltshire , UK , SN58RU Glaxo SmithKline , Research Triangle Park , NC 27709 , Made England ) healthy , male female adult , human study participant fast condition . • To monitor clinical status , adverse event , laboratory investigation assess relative safety tolerance ondansetron formulation fast condition .</brief_summary>
	<brief_title>Cross-over Bioequivalence Fasting Study Compare Ondansetron Oral Soluble Film ( OSF ) With Zofran Orally Disintegrating Tablets ( ODT )</brief_title>
	<detailed_description />
	<mesh_term>Ondansetron</mesh_term>
	<criteria>Inclusion Criteria The criterion inclusion : Study volunteer provide write informed consent . Study volunteer must healthy adult within 1845 year age ( inclusive ) . Study volunteer Body mass index ³ 18.5 kg/m2 £ 25 kg/m2 , body weight less 50 kg . Study volunteer systolic blood pressure upper limit le 140 mmHg low limit equal 90 mm Hg . Similarly diastolic blood pressure upper limit le 90 mm Hg low limit equal 60 mmHg . Study volunteer must normal health determine medical history physical examination perform within 15 day prior dose period 1 . Study volunteer normal ECG , chest Xray vital sign . Availability study volunteer entire study period willingness adhere protocol requirement evidence write informed consent . If study volunteer female child bear potential practicing acceptable method birth control duration study judge investigator ( ) , condom , foam , jelly , diaphragm , intrauterine device ( IUD ) , abstinence . full menopause , i.e. , postmenopausal least 1 year . surgically sterile ( bilateral tubal ligation , bilateral oophorectomy , hysterectomy perform study volunteer ) Each female study volunteer give urine pregnancy test screening , checkin period1 , period2 post study . Exclusion Criteria The study participant exclude base follow criterion : Study volunteer incapable understanding informed consent . Study volunteer history hypersensitivity idiosyncratic reaction study drug relate drug . Study volunteer evidence impairment renal , hepatic , cardiac , lung gastrointestinal function , standard laboratory , image monitoring procedure { The normal range laboratory testvalues follow per clinical reference laboratory , VIMTA VHS Research Centre , Chennai ( A unit Vimta Labs Ltd. , Hyderabad ) } . Study volunteer history tuberculosis , epilepsy , asthma ( past 5 year ) , diabetes , psychosis glaucoma eligible study . Study volunteer smoke regularly ten cigarette daily difficulty abstain smoke duration study period . Study volunteer take counter prescribed medication , include enzyme modifying drug Phenytoin , Carbamazepine , barbiturates , St. John wort , glucocorticoid , ketoconazole , itraconazole , erythromycin , clarithromycin calcium channel blocker systemic medication within past 30 day prior dose first period systemic medication within past 30 day prior dose first period . Study volunteer history psychiatric illness , may impair ability provide write , informed consent full participation cooperation study protocol . Study volunteer history alcohol substance abuse within last 5 year . Study volunteer clinically significant abnormal value laboratory parameter . Study volunteer participate clinical investigation use experimental drug bleed 350 mL past 3 month . Study volunteer unable likely noncompliant protocol requirement restriction . Study volunteer study drug contraindicate medical reason Study volunteer intolerant venipuncture . Female volunteer use implant injected hormonal contraceptive anytime 6 month prior study use hormonal contraceptive within 14 day dose . Female volunteer demonstrate positive pregnancy screen urine pregnancy test ( strip method ) . Ondansetron 8 mg ODFS BE Fasting Study Study No . : 01905/0809 ; Protocol No . : OND/CR/020/0809 Version No . : 01 Date : 28 Jan 2009 Confidential Page 24 49 Each female study volunteer screen pregnancy screening , checkin study period . Study volunteer positive inconclusive result withdrawn study . Female volunteer currently breast feed . Female study volunteer pregnant , breastfeed likely become pregnant study allow participate . Female study volunteer child bear potential must either abstain sexual intercourse use reliable barrier method ( e.g . condom , IUD ) contraception course study ( first dose last blood collection ) allow participate . Study volunteer positive urine screen drug abuse time admission checkin period exclude study . Study volunteer meet inclusion exclusion criterion verify medical investigator per source document duly authenticate reflect clinical judgment require .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>June 2011</verification_date>
</DOC>